laitimes

Ningxia Jinwei Pharmaceutical Vitamin B2 Project relocated, Xinhua Pharmaceutical: The company did not produce vaccine raw materials

author:Domestic veterinary drug raw materials market information

News alerts

Jiangxi Tianxin Pharmaceutical Co., Ltd. intelligent transformation

Ningxia Changsheng Pharmaceutical invested in the construction of annual output and other pharmaceutical intermediate projects

Ningxia Jinwei Pharmaceutical series food, feed additives and other projects relocation planning before the approval of the public announcement

Meihua Group MSG market quotation increased by 100 yuan / ton, began to accept limited orders

The volume and price of soda ash, the leading product of Shandong Haihua, increased together, and the loss turned into a profit in the first half of the year

Sinopec and BASF announced on August 5 that their joint venture, BASF CO., Ltd. will expand its integrated production site in Nanjing

Veterinary drug enterprises rushed to henan

The disaster was affected by a wide range of areas, and the local animal husbandry industry was also affected to varying degrees. In particular, the risk of epidemic diseases increases after flood disasters, and the disinfection and sanitation after disasters should not be underestimated. According to statistics, Shanghai Haili Biotechnology Co., Ltd., Shenlian Biological (Shanghai) Co., Ltd., Shanghai Tongren Pharmaceutical Co., Ltd. Shanghai Veterinary Pharmaceutical Factory, Lilan (Shanghai) Animal Health Co., Ltd., Shanghai Xinyuan Pet Food Co., Ltd., Shanghai Hanwei Biomedical Technology Co., Ltd., Shanghai Paisde Animal Health Products Co., Ltd., Shanghai Kangchen Biotechnology Co., Ltd. and other 8 veterinary drug manufacturers donated cash, disinfectants and drugs to the disaster area and other relief materials, worth 5 million yuan. Related materials will be gradually deployed to the local area.

Xinhua Pharmaceutical

On August 5, Lin Bingyong, member of the party group and deputy director of the Shandong Provincial Food and Drug Administration, and three other people, accompanied by Wang Limin, director of the Third Branch of the Regional Inspection of the Provincial Food and Drug Administration, and Su Kai, director of the Zibo Municipal Market Supervision and Administration Bureau, and other leaders, went to Xinhua Pharmaceutical to conduct research and inspection. Zhang Daiming, secretary of the party committee and chairman of the board of directors of the company, Wei Changsheng, deputy general manager, and Liu Xuesong, director of preparation quality, accompanied the investigation.

Ningxia Jinwei Pharmaceutical Vitamin B2 Project relocated, Xinhua Pharmaceutical: The company did not produce vaccine raw materials

Every time the AI newsletter, some investors ask questions on the investor interaction platform: Does the company produce THE NEW CROWN vaccine API?

Xinhua Pharmaceutical (000756. SZ) said on August 4 on the investor interactive platform, Hello! The company does not produce vaccine raw materials, thank you!

Pharmaceutical companies are listed

On August 5, the Issuance review committee of the China Securities Regulatory Commission held the 83rd issuance review meeting in 2021, and deliberated the IPO application of the main board of Shaanxi Meibang Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Meibang Pharmaceutical"), and Meibang Pharmaceutical successfully passed the meeting.

2021 Shandong Livestock Expo

The exhibition covers an area of 80,000 square meters, attracting more than 1,000 leading brand enterprises from key animal husbandry production areas in the country to participate in the exhibition, attracting nearly 100,000 professional merchants. The exhibition covers four categories: breeding equipment, veterinary drugs, feed, livestock products, according to statistics, last year's 35th Shandong Animal Husbandry Expo site agreement intention transaction volume reached 1.6 billion yuan. The list of the first exhibitors has been announced.

Ningxia Jinwei Pharmaceutical Vitamin B2 Project relocated, Xinhua Pharmaceutical: The company did not produce vaccine raw materials

202021 The Central Plains Animal Husbandry Trade Expo

Due to the recent new local cases of the new crown pneumonia epidemic in many parts of the country, in order to actively cooperate with the national epidemic prevention and control work and effectively protect the health and safety of the participants, after careful consideration by the organizing committee, the 33rd Central Plains Animal Husbandry Trade Expo (Henan Poultry Fair), which was originally scheduled to be held at the Zhengzhou International Convention and Exhibition Center on August 23-24, 2021, was postponed to December 15-16, 2021.

Paracetamol project

The world's largest paracetamol wet granulation technology transformation project, after four and a half months of intense construction and production commissioning, was successfully completed and put into operation in Anqiu Luan Pharmaceutical Co., Ltd.

Paracetamol wet granulation technology transformation project in accordance with the national GMP standards and THE UNITED STATES FDA standard design and construction, the introduction of automatic, highly intelligent production, warehousing and robots and other equipment, all material transportation using closed vacuum transportation, the annual production of compound paracetamol granules 8000 tons, can fully meet the needs of customers at home and abroad, prompting enterprises to further deepen the international high-end market.

Ningxia Jinwei Pharmaceutical Vitamin B2 Project relocated, Xinhua Pharmaceutical: The company did not produce vaccine raw materials

New version of veterinary drug GMP certification

According to the "Good Manufacturing Practice for Veterinary Drugs (Revised in 2020)" and Announcement No. 292 of the Ministry of Agriculture and Rural Affairs of the People's Republic of China, in accordance with the relevant provisions of the "Measures for the Inspection and Acceptance of Good Manufacturing Practices for Veterinary Drugs" and other relevant provisions, the Shandong Provincial Bureau of Animal Husbandry and Veterinary Medicine sent an inspection team to conduct on-site inspection and acceptance of the implementation of veterinary drug GMP by shandong Shengyang Biological Engineering Co., Ltd. and Shandong Saito Biotechnology Co., Ltd., and the on-site inspection and acceptance is now announced on the official website of the Shandong Provincial Bureau of Animal Husbandry and Veterinary Medicine. The announcement period is from July 30, 2021 to August 13, 2021.

Ningxia Jinwei Pharmaceutical Vitamin B2 Project relocated, Xinhua Pharmaceutical: The company did not produce vaccine raw materials

Pharmaceutical companies were punished

On July 30, the Sichuan Provincial Food and Drug Administration published information on five administrative punishment cases, of which 3 pharmaceutical companies (1 pharmaceutical company was punished twice) were fined 134,454,555 yuan for the production and sale of inferior drugs, and 1 pharmaceutical company was fined 250,000 yuan for selling inferior drugs.

Victory creatures

Recently, the State-owned Assets Supervision and Administration Commission of the State Council announced the list of benchmarking enterprises, benchmarking projects and benchmarking models for the creation of state-owned key enterprise management benchmarking, and Shengli Bio won the title of "Benchmarking Enterprise", becoming the only enterprise of China Agricultural Development Group to receive this honor.

Ningxia Jinwei Pharmaceutical Vitamin B2 Project relocated, Xinhua Pharmaceutical: The company did not produce vaccine raw materials

Read on